AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 375858
Drug: 10-mg troche,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-mg troche, five times a day for two weeks
Trial: 375858
Drug: 50-mg troche,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50-mg troche, five times a day for two weeks
Trial: 30593775
Drug: CsA CE
RxNorm normalized name: CsA
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CsA CE 0.1% (1 mg/ml) eye drops 4 times daily (high dose)
Trial: 30593775
Drug: CsA CE
RxNorm normalized name: CsA
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CsA CE twice daily (low dose) plus vehicle twice daily
Trial: 30593775
Drug: Vehicle 4
RxNorm normalized name: meningococcal group B vaccine / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle Prefilled Syringe [Bexsero]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vehicle 4 times daily
Trial: 30593775
Drug: High-dose CsA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose CsA CE
Trial: 30593775
Drug: Low-dose CsA
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose CsA CE
Trial: 16167722
Drug: Intravaginal misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravaginal misoprostol (250 mcg every four hours)
Trial: 10708161
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human growth hormone (0.15 mg rhGH/kg/day)
Trial: 9210530
Drug: Total parenteral
RxNorm normalized name: TPN - total parenteral nutrition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total parenteral nutrition alone
Trial: 9396090
Drug: Glyceryl trinitrate
RxNorm normalized name: Glyceryl trinitrate
DrugBank: Nitroglycerin (DB00727)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glyceryl trinitrate ointment (2%)
Trial: 9396090
Drug: Nicotinic acid
RxNorm normalized name: Nicotinic acid
DrugBank: Niacin (DB00627)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotinic acid ointment (10%)
Trial: 8135384
Drug: No additional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No additional medication (BG)
Trial: 2680795
Drug: Colloidal bismuth
RxNorm normalized name: Colloidal bismuth subcitrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colloidal bismuth subcitrate (CBS) 240 mg twice daily
Trial: 797554
Drug: Desonide cream
RxNorm normalized name: Desonide Cream
DrugBank: Desonide sodium phosphate (DB15835)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Desonide cream
Trial: 797547
Drug: Fluocinonide cream
RxNorm normalized name: Fluocinonide Cream
DrugBank: Fluocinonide (DB01047)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluocinonide cream
Trial: 31053405
Drug: Cisplatin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin (50 mg/m2) and Doxorubicin (45 mg/m2)
Trial: 31053405
Drug: Cisplatin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin (50 mg/m2), Doxorubicin (45 mg/m2), and Paclitaxel (160 mg/m2)
Trial: 27931762
Drug: Intranasal ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal ketamine 1 mg/kg
Trial: 25080875
Drug: Multidisciplinary treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multidisciplinary treatment (combining pharmacological treatment, education, physical therapy, and cognitive behavioural therapy)
Trial: 22899402
Drug: Conventional pharmacologic
RxNorm normalized name: COPD pharmacologic substance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional pharmacologic treatment
Trial: 1397477
Drug: Bezafibrate (BZF)
RxNorm normalized name: bezafibrate
DrugBank: Bezafibrate (DB01393)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bezafibrate (BZF) 400 mg/day for one month
Trial: 1397477
Drug: Acipimox (APX)
RxNorm normalized name: acipimox
DrugBank: Acipimox (DB09055)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acipimox (APX) 500 mg/day for one month
Trial: 3554901
Drug: Nitrazepam (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrazepam (10 mg nocte)
Trial: 3554901
Drug: Temazepam (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temazepam (20 mg nocte)
Trial: 30154027
Drug: MONEO platform
RxNorm normalized name: tiotropium bromide mono
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MONEO platform (smartphone-based), cognitive training twice a week, assessed monthly via teleconference
Trial: 29864505
Drug: Inorganic NO3-
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inorganic NO3- supplementation (beetroot powder; 250 mg of NO3- and 20 mg of NO2-) for four weeks
Trial: 24769563
Drug: Essential oils
RxNorm normalized name: essential oils
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Essential oils in ethanolic solution mouthrinse
Trial: 23232161
Drug: Virtual Reality
RxNorm normalized name: RelieVRx Virtual Reality Behavioral Therapy for Pain Relief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Virtual Reality (VR) training combined with Conventional Therapy (CT)
Trial: 15840746
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate (150 mg for 5 days from the third day of a progesterone withdrawal bleeding)
Trial: 12477504
Drug: IV albumin
RxNorm normalized name: albumin human, USP Injection [Albuminar]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV albumin treatment for OHSS
Trial: 12477504
Drug: Women with
RxNorm normalized name: Arthricare for Women Moisturizing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Women with OHSS before treatment
Trial: 9790269
Drug: TAP-144SR (long-acting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAP-144SR (long-acting gonadotropin-releasing hormone analog)
Trial: 28731609
Drug: Dietary sodium
RxNorm normalized name: sodium phosphate, monobasic
DrugBank: Sodium phosphate, monobasic (DB09449)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dietary sodium intake (mean Na intake: 4309.6 ± 1344.4 mg/day)
Trial: 19627212
Drug: Honey solution
RxNorm normalized name: Honey
DrugBank: Honey (DB14242)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Honey solution (75 g once daily for 14 days)
Trial: 19627212
Drug: Sugar solution
RxNorm normalized name: Invert Sugar
DrugBank: Invert sugar (DB09344)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugar solution (honey-comparable, 75 g once daily for 14 days)
Trial: 9632446
Drug: Hyperfractionated irradiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hyperfractionated irradiation plus concurrent chemotherapy (combined treatment)
Trial: 8148291
Drug: Subarachnoid morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subarachnoid morphine sulfate 0.25 mg and fentanyl 25 micrograms via CSE technique
Trial: 20886729
Drug: Administration of
RxNorm normalized name: IV solutions used in parenteral administration of fluids, electrolytes and nutrients
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Administration of immunomodulators
Trial: 15905656
Drug: Computer-aided dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computer-aided dosing of warfarin (n=14)
Trial: 15905656
Drug: Clinician dosing
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinician dosing of warfarin (n=16)
Trial: 9178167
Drug: Riluzole 100
RxNorm normalized name: Riluzole
DrugBank: Riluzole (DB00740)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Riluzole 100 mg daily
Trial: 10741628
Drug: 50 mg/day
RxNorm normalized name: infigratinib phosphate 50 mg/day (25 mg x 2) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg/day oral mibefradil for 8 days
Trial: 10741628
Drug: 100 mg/day
RxNorm normalized name: infigratinib phosphate 100 mg/day (100 mg x 1) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg/day oral mibefradil for 8 days
Trial: 21640574
Drug: Indomethacin 100
RxNorm normalized name: indomethacin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin 100 mg
Trial: 1353717
Drug: salbutamol 5
RxNorm normalized name: Salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: salbutamol 5 mg
Trial: 1353717
Drug: fenoterol 5
RxNorm normalized name: fenoterol 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fenoterol 5 mg
Trial: 8885761
Drug: normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: normal saline solution
Trial: 6342295
Drug: Injection with
RxNorm normalized name: Temsirolimus 25mg/1mL Solution for injection with Diluent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection with procaine hydrochloride (control)
Trial: 31771512
Drug: Deep cervical
RxNorm normalized name: Deep Sea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deep cervical block (DCB) receiving 20 mL ropivacaine 0.5% (n=10)
Trial: 31771512
Drug: Intermediate cervical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermediate cervical block (ICB) receiving 20 mL ropivacaine 0.5% (n=10)
Trial: 31771512
Drug: Perivascular infiltration
RxNorm normalized name: Autologous tumor infiltrating lymphocytes
DrugBank: Lifileucel (DB17107)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perivascular infiltration of the internal carotid artery (PVB) receiving 20 mL ropivacaine 0.5% and 10 mL ropivacaine 0.3% (n=10)
Trial: 26362785
Drug: Preoperative decolonization
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative decolonization treatment for S aureus carriers
Trial: 26362785
Drug: Noncarriers (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Noncarriers (no treatment)
Trial: 25495568
Drug: Furosemide and
RxNorm normalized name: furosemide and potassium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide and standard-dosed Solifenacin (10 mg per day)
Trial: 25495568
Drug: Furosemide and
RxNorm normalized name: furosemide and potassium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide and low-dosed Solifenacin (5 mg per day)
Trial: 22521671
Drug: Preoperative ibuprofen
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Preoperative ibuprofen (600 mg p.o. 1h before surgery)
Trial: 22521671
Drug: Postoperative ibuprofen
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Postoperative ibuprofen (placebo after surgery)
Trial: 17695436
Drug: Combination chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination chemotherapy (CF: cisplatin and 5-fluorouracil)
Trial: 16121218
Drug: Intensive regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive regimen including mitoxantrone plus cytarabine, two consolidation courses, one with timed-sequential high-dose cytarabine, asparaginase and amsacrine.
Trial: 16121218
Drug: No maintenance
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No maintenance therapy (MT-).
Trial: 16121218
Drug: Maintenance therapy
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance therapy (MT).
Trial: 10100788
Drug: Carotid endarterectomy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carotid endarterectomy (CEA) with best medical therapy
Trial: 7785280
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg Volon A
Trial: 7785280
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg Volon A
Trial: 2272190
Drug: Controlled-release trazodone
RxNorm normalized name: trazodone hydrochloride Extended Release Oral Tablet [Molipaxin CR]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled-release trazodone (150 mg)
Trial: 2272190
Drug: Standard trazodone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard trazodone (150 mg)
Trial: 12653747
Drug: Photodynamic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photodynamic therapy (PDT) with 20% 5-aminolaevulinic acid (ALA) applied 4 hours before illumination with 100 J cm‐2 narrowband red light (630 +/- 15 nm)
Trial: 12653747
Drug: Topical 5-fluorouracil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 5-fluorouracil (5-FU) applied to lesions for 4 weeks, with a repeat treatment cycle after 6 weeks if required
Trial: 11053909
Drug: Levofloxacin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levofloxacin (100 mg t.d.s. orally for 5 days)
Trial: 11053909
Drug: Cefazolin sodium
RxNorm normalized name: Cefazolin Sodium
DrugBank: Cefazolin (DB01327)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefazolin sodium (1 g b.i.d. intravenously for 5 days)
Trial: 9198569
Drug: Tension-free surgical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tension-free surgical treatment
Trial: 3455938
Drug: 0.2% CH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2% CH gel
Trial: 3455938
Drug: 0.2% CH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2% CH solution
Trial: 25045152
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg genistein provided as a genistein tablet
Trial: 25045152
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg genistein provided as a genistein tablet in low fat milk
Trial: 25045152
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg genistein provided as soy milk containing genistein glycosides
Trial: 22533447
Drug: Etanercept plus
RxNorm normalized name: Etanercept
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Etanercept plus methotrexate (7·5‐15 mg weekly)
Trial: 18401809
Drug: Whole-body vibration
RxNorm normalized name: Insects (whole body), mite dermatophagoides farinae
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole-body vibration (WBV) at 30 Hz and 4 mm amplitude for 60 seconds, repeated twice
Trial: 16091231
Drug: New antiretroviral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New antiretroviral drugs used carefully with an active background regimen
Trial: 16091231
Drug: Resistance testing
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resistance testing and drug level monitoring
Trial: 16091231
Drug: Multiple-drug regimens
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple-drug regimens
Trial: 11690728
Drug: Pregabalin (exact
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin (exact dosage not specified)
Trial: 27598553
Drug: Proprioceptive/strengthening exercises
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proprioceptive/strengthening exercises combined with manual therapy (mobilizations to influence joint and nerve structures)
Trial: 23538020
Drug: Ezetimibe added
RxNorm normalized name: Ezetimibe
DrugBank: Ezetimibe (DB00973)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ezetimibe added to maximum tolerated statin therapy
Trial: 23538020
Drug: Maximum tolerated
RxNorm normalized name: Maximum-H
DrugBank: Hydrocortisone (DB00741)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Maximum tolerated statin therapy without ezetimibe
Trial: 20655105
Drug: Rosuvastatin 20
RxNorm normalized name: rosuvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin 20 mg per day
Trial: 18211506
Drug: Steroid-free group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid-free group (n = 112)
Trial: 18211506
Drug: Steroid withdrawal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid withdrawal group (n = 115)
Trial: 18211506
Drug: Standard steroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard steroids group (n = 109)
Trial: 16984076
Drug: Multiple-family group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple-family group treatment (MFGT)
Trial: 10920067
Drug: Carvedilol (49±18
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol (49±18 mg/d)
Trial: 10920067
Drug: Metoprolol (124±55
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (124±55 mg/d)
Trial: 1551312
Drug: Intravenous metformin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous metformin infusion
Trial: 6485438
Drug: NaCl infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: NaCl infusion (control)
Trial: 30113051
Drug: Probiotic supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic supplements (8 × 10^9 CFU day‐1) for 12 weeks
Trial: 24668063
Drug: Standard care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard care (RadiaPlexRx™ ointment) applied topically three times a day until 1 month postradiation
Trial: 19945545
Drug: Thyroid hormone
RxNorm normalized name: Thyroid hormone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thyroid hormone supplementation in brain stem death setting
Trial: 12633121
Drug: Risperidone (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone (mean dose 0.95 mg/day)
Trial: 3912960
Drug: Omeprazole 10
RxNorm normalized name: omeprazole 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 10 mg/day
Trial: 7460480
Drug: Acebutolol (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acebutolol (400 mg three times a day)
Trial: 31237644
Drug: 1 month
RxNorm normalized name: LUPRON-PED 15MG (1 MONTH) SA INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 month of DAPT followed by clopidogrel monotherapy
Trial: 31237644
Drug: 12 months
RxNorm normalized name: Elecare HMO 0-12 Months
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 months of DAPT with aspirin and clopidogrel
Trial: 29228964
Drug: Probiotics (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotics (2.5 × 10^9 cfu/g) containing Bifidobacterium bifidum W23, Bifidobacterium lactis W52, Lactobacillus acidophilus W37, Lactobacillus brevis W63, Lactobacillus casei W56, Lactobacillus salivarius W24, Lactococcus lactis W19 and Lactococcus lactis W58 (Ecologic®Barrier)
Trial: 26387049
Drug: Alcohol-Adapted Anger
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcohol-Adapted Anger Management Treatment (AM)
Trial: 26387049
Drug: Alcoholics Anonymous
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcoholics Anonymous Facilitation treatment (AAF)
Trial: 16739840
Drug: Needle-knife therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Needle-knife therapy
Trial: 15010365
Drug: Alendronate (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate (40 mg/d)
Trial: 10918156
Drug: Microwave coagulation
RxNorm normalized name: Coagulation factor XIa
DrugBank: Coagulation factor XIa (DB15420)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microwave coagulation therapy (14 patients)
Trial: 10918156
Drug: Microwave coagulation
RxNorm normalized name: Coagulation factor XIa
DrugBank: Coagulation factor XIa (DB15420)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microwave coagulation therapy
Trial: 8791968
Drug: Cimetidine >
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine > or = 2 g daily
Trial: 8791968
Drug: Cimetidine (general
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (general treatment)
Trial: 28434547
Drug: Stress-dose corticosteroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stress-dose corticosteroid (SDC) regimen
Trial: 31284871
Drug: Intravenous Ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous Ketamine (0.3 mg/kg)
Trial: 31284871
Drug: Intravenous Morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous Morphine (0.1 mg/kg)
Trial: 19863578
Drug: Carisbamate 400
RxNorm normalized name: Chlorphenesin Carbamate
DrugBank: Chlorphenesin carbamate (DB14656)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carisbamate 400 mg/day
Trial: 10505300
Drug: Cerivastatin 0.05‐0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cerivastatin 0.05‐0.8 mg orally, given as single or multiple once‐daily doses
Trial: 10505300
Drug: Cerivastatin administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cerivastatin administered at different times (morning, evening meal, bedtime)
Trial: 10505300
Drug: Marketed tablet
RxNorm normalized name: acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Marketed tablet strengths and drug formulations from different sources
Trial: 8605793
Drug: Intravenous bolus
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous bolus of murine monoclonal antibody to E‐selectin, CY1787 at 0.1 mg/kg (n = 3)
Trial: 8605793
Drug: Intravenous bolus
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous bolus of murine monoclonal antibody to E‐selectin, CY1787 at 0.33 mg/kg (n = 3)
Trial: 8605793
Drug: Intravenous bolus
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous bolus of murine monoclonal antibody to E‐selectin, CY1787 at 1.0 mg/kg (n = 3)
Trial: 8605793
Drug: Intravenous bolus
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous bolus of murine monoclonal antibody to E‐selectin, CY1787
Trial: 1709039
Drug: Spantide (substance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spantide (substance P antagonist)
Trial: 1709039
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no substance P antagonist)